Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis

PHASE4CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Chronic Uveitis
Interventions
DRUG

infliximab

5mg/kg/dose IV at 4 week intervals

DRUG

infliximab

10mg/kg/dose IV at 4 week intervals

Trial Locations (1)

27710

Duke University Medical Center, Durham

All Listed Sponsors
collaborator

Childhood Arthritis and Rheumatology Research Alliance

OTHER

lead

Egla C. Rabinovich

OTHER

NCT00589628 - Multi Center Prospective Registry of Infliximab Use for Childhood Uveitis | Biotech Hunter | Biotech Hunter